Letter of Intent for entities external to the INCISIVE consortium!
Hospitals can now become contributors to the INCISIVE Hybrid Repository by providing anonymized multimodal medical images available at their institution.
More ℹ️in the📜: https://t.co/2alDrH20nK
📢 Announcement: The #PRIMAGE final review meeting just ended. We thank all the consortium partners for their input during today's meeting. Special thanks to #HADEA reviewers for sharing inspiring thoughts and valuable recommendations with us.
#ChildhoodCancer#euCancerImaging
📣 We are #hiring a Society Administrator!
🎗️ If you are passionate about making life-changing differences to the lives of people affected by #ChildhoodCancer, then this might be the job for you.
🗓️ Application deadline: 31 July 2023
ℹ️ More information: https://t.co/Ti1mVWlzxO
📢1/7: The #EUPharmaStrategy proposal was released and for #EWAC2023 we’d like to share our expectations.
🎗️We asked the European #ChildhoodCancer community how the legislation could accelerate medicine development for children?
🤔Share your thoughts by using #EUPharma4Children
The #PrimageProject Consortium Meeting has concluded 🎗️We would like to thank all 16 partners for their continued efforts and contributions to #ChildhoodCancer ✅
More info 🔗 https://t.co/Or9jkW3bGt
🔴Live from the #PrimageProject Plenary in Valencia, @SIOPEurope is presenting the dissemination and communication achievements:
🎗️30+ meetings
🎗️social media reach and engagement
🎗️25 publications
For more info about the project, visit 🔗 https://t.co/TixKvNP1sm
#ChildhoodCancer
🎗️The #PrimageProject is almost coming to end and the Consortium Meeting is being held on 22-23 May in Valencia, Spain to exchange and prepare the final results of the project 🎯
Find out more 🔗 https://t.co/Or9jkW2DQV
#ChildhoodCancer
🎗️ If you want to stay up to date with the European #ChildhoodCancer community, then sign up to our triannual newsletter - next edition coming out in May!
📩 Sign up by sending an email to: [email protected]
🖥️ Read previous editions here: https://t.co/5cen79GMp3
If you are attending #SIOPEurope23, do not miss the #PrimageProject presentation on 9 May from 12:30 to 13:00 CET at the Project in the Spotlight session to find out more about how this project - and many others, contribute to #ChildhoodCancer🎗️ More info🔗https://t.co/XX5kZ9loho
📢 We are looking for #volunteers to support the SIOP Europe Annual Meeting taking place on 8-12 May 2023 in #Valencia, Spain🎗️
Support the meeting & get a free registration on a different day of your choice ✅
More info 🔗https://t.co/arabGx1bPB
#ChildhoodCancer
🎗️#ERNPaedCan Most Challenging Cases webinars provide spaces for young oncologists to present & be paired with experienced #PaediatricOncology professionals🔁Best practice exchanges promote #innovation & #progress 🎯Submit a case or register! More info: https://t.co/0v0jgBQgtM
🎗️ On 7 March, the #PaediatricOncology community lost a prominent contributor. Sverre Lie’s outstanding achievements in acute lymphatic #leukaemia treatment will continue saving the lives of #childhoodcancer patients long after his. Our thoughts and wishes go out to his family 🕊️
📣 We are #Hiring🎗️If you are passionate about #HealthPolicy and making life-changing differences to the lives of people affected by #ChildhoodCancer, then this might be the right job for you 🎯
More info🔗 https://t.co/jcmnhbsmNB
Help spread the word 👉 Share with your network🙏
📣 The first report from six #QUARTETProject-affiliated trials is out 🎗️
Read their findings on #Radiotherapy quality assurance in #PaediatricOncology clinical trials, here 👉 https://t.co/xokSS1oLE0
Today is #RareDiseaseDay 🎗️ #ChildhoodCancer is a rare disease yet every 15 minutes in Europe, a family receives the devastating news that their child has cancer. Together, we can cure more & cure better 🎯 Help raise awareness 👉 like & share 🙏
📣 The #QUARTETProject is recruiting a Fellow in #PaediatricOncology#Radiotherapy Quality Assurance ✅
🎯 This project aims to improve effectiveness of radiotherapy to achieve better outcomes for #ChildhoodCancer patients 🎗️
More info, visit 👉 https://t.co/mLqXRkFKjv